全文获取类型
收费全文 | 21229篇 |
免费 | 1375篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 223篇 |
儿科学 | 558篇 |
妇产科学 | 432篇 |
基础医学 | 3329篇 |
口腔科学 | 532篇 |
临床医学 | 2077篇 |
内科学 | 4650篇 |
皮肤病学 | 531篇 |
神经病学 | 2485篇 |
特种医学 | 626篇 |
外科学 | 1803篇 |
综合类 | 109篇 |
一般理论 | 13篇 |
预防医学 | 1840篇 |
眼科学 | 417篇 |
药学 | 1336篇 |
中国医学 | 78篇 |
肿瘤学 | 1662篇 |
出版年
2024年 | 36篇 |
2023年 | 207篇 |
2022年 | 410篇 |
2021年 | 693篇 |
2020年 | 465篇 |
2019年 | 655篇 |
2018年 | 697篇 |
2017年 | 532篇 |
2016年 | 631篇 |
2015年 | 742篇 |
2014年 | 881篇 |
2013年 | 1097篇 |
2012年 | 1768篇 |
2011年 | 1884篇 |
2010年 | 1001篇 |
2009年 | 905篇 |
2008年 | 1477篇 |
2007年 | 1477篇 |
2006年 | 1393篇 |
2005年 | 1304篇 |
2004年 | 1206篇 |
2003年 | 1085篇 |
2002年 | 926篇 |
2001年 | 112篇 |
2000年 | 73篇 |
1999年 | 117篇 |
1998年 | 180篇 |
1997年 | 154篇 |
1996年 | 111篇 |
1995年 | 87篇 |
1994年 | 68篇 |
1993年 | 48篇 |
1992年 | 31篇 |
1991年 | 22篇 |
1990年 | 34篇 |
1989年 | 21篇 |
1988年 | 15篇 |
1987年 | 18篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 11篇 |
1981年 | 9篇 |
1980年 | 15篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1975年 | 6篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Bußkamp Annalena Vonstein Claudia Tillmann Judith Roßmann Christin De Bock Freia 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2021,64(5):560-567
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Wissenschaftliche Ergebnisse können eine Wissensquelle für kommunale Akteurinnen und Akteure der... 相似文献
102.
103.
104.
Vassão Patricia Gabielli Parisi Julia Penha Thaíse Fernanda Campos Balão Ana Beatriz Renno Ana Claudia Muniz Avila Mariana Arias 《Lasers in medical science》2021,36(7):1341-1353
Lasers in Medical Science - Knee osteoarthritis (KOA) is a common degenerative disease in which several treatments and treatment associations have been investigated. This review analyzed the... 相似文献
105.
Mireia Ruiz-Castilla Bruce Dos Santos Claudia Vizcaíno Jacinto Baena Patricia Guilabert Judith Marin-Corral Joan R. Masclans Oriol Roca Juan P. Barret 《Burns : journal of the International Society for Burn Injuries》2021,47(4):906-913
IntroductionSeveral mechanisms play a role in the development of pneumonia after inhalation injury. Our aim was to analyze whether higher concentrations of inflammatory markers or of biomarkers of epithelial injury are associated with a higher incidence of pneumonia in patients with inhalation injury.Material and methodsSecondary analysis of a single-center prospective observational cohort pilot study, performed over a two-year period (2015–2017) at the Burns Unit of the Plastic and Reconstructive Surgery Department of Vall d’Hebron University Hospital. All patients aged 18 with suspected inhalation injury undergoing admission to the Burns Unit were included. Plasma biomarkers of the lung epithelium (RAGE and SP-D), inflammation markers (IL6, IL8), and IL33, as well as soluble suppression of tumorigenicity-2 (sST2) levels, were measured within the first 24 h of admission.ResultsTwenty-four patients with inhalation injury were included. Eight (33.3%) developed pneumonia after a median of 7 (4–8) days of hospital stay. Patients with pneumonia presented higher plasma concentrations of sST2 (2853 [2356–3351] ng/mL vs 1352 [865–1839] ng/mL; p < 0.001), IL33 (1.95 [1.31–2.59] pg/mL vs 1.26 [1.07–1.45] pg/mL; p = 0.002) and IL8 (325.7 [221.6–430.0] pg/mL vs 174.1 [95.2–253.0] pg/mL; p = 0.017) on day 1 of inclusion. Plasma sST2 concentration in the first 24 h demonstrated excellent diagnostic accuracy for predicting the occurrence of pneumonia in patients with smoke inhalation (AUROC 0.929 [95%CI 0.818–1.000]). A cutoff point of ≥2825 ng/mL for sST2 had a sensitivity of 75% and a specificity of 100%. The risk ratio of pneumonia in patients with sST2 ≥ 2825 ng/mL was 7.14 ([95% CI 1.56–32.61]; p = 0.016).ConclusionsPlasma sST2 in the first 24 h of admission predicts the occurrence of pneumonia in patients with inhalation injury. 相似文献
106.
Daniela de Queiroz Moura Ramon Rawache Marília Ferreira Gomes Garcia Nathalia Farias Vasconcelos Priscila Santos Gustavo Rego Coelho Thiago Luis da Paz Santos Duílio Reis da Rocha Filho Sonia Leite da Silva Eliana Regia Barbosa de Almeida Paula F.C.B.C. Fernandes João Batista Cerqueira José Huygens Parente Garcia Claudia Maria Costa de Oliveira 《Transplantation proceedings》2021,53(4):1345-1349
Transplantation of any organ has some inherent risk of disease transmission, such as infection and malignancy. The present study aims to describe 2 cases of choriocarcinoma transmission after kidney and liver transplantation originating from the same patient. The donor was a 17-year-old woman who died of cerebral hemorrhage. Both organ recipients died of metastatic choriocarcinoma few months after the transplantation, within days after starting chemotherapy. Retrospective hCG (human chorionic gonadotropin hormone) analysis in donor's blood stored at the time of donation had a result of 9324 mIU/mL. Despite its rarity, clinicians should be aware of the risk of transplant-related choriocarcinoma from female donors in childbearing age. In some cases, hCG dosage should be performed before donation. 相似文献
107.
108.
109.
Juliana Cervantes-Theurel Alejandra Albarran-Sanchez Victor Rodriguez-Perez Etual Espinosa-Cardenas Claudia Ramirez-Renteria Aldo Ferreira-Hermosillo 《Surgery for obesity and related diseases》2021,17(2):257-262
BackgroundObstructive sleep apnea–hypopnea syndrome (OSAHS) is present in 80% of patients evaluated for bariatric surgery (BS). Extensive evaluation is not widely available, but treatment is mandatory for severe cases. The Snore, Tiredness, Observed apneas and Pressure - Body mass index, Age, Neck circumference and Gender (STOP-Bang) and Epworth questionnaires and neck-to-height ratio (NHtR) are accessible clinical tools to screen for sleep and metabolic disturbances, but their utility to detect severe OSAHS in patients with severe obesity has not been determined.ObjectivesTo evaluate the cutoff point of those clinical tools that may predict severe OSAHS, confirmed by polysomnography in patients referred for BS.SettingTertiary referral center in Mexico City.MethodsWe applied the STOP-Bang and Epworth questionnaires, evaluated anthropometric characteristics, and collected samples for arterial gasometry and metabolic parameters from 68 patients with severe obesity, who were then referred for polysomnography before their evaluation for BS.ResultsOf the 68 patients participating in the study, 67.7% were female, with a median age of 43 years (35–49 years) and a body mass index (BMI) of 45.5 kg/m2 (42.4–50.9 kg/m2; 28.3% had a BMI ≥ 50 kg/m2). A STOP-Bang cutoff >5 points had a sensitivity of 60% and specificity of 90% for detecting severe OSAHS (area under the curve [AUC] = .962); meanwhile, an NHtR >.25 had a sensitivity of 90% and specificity of 52.5% (AUC = .759). The Epworth scale score >11 points had a sensitivity of 57.1% and specificity of 83.3% (AUC = .802).ConclusionClinical data may be useful to detect severe sleep apnea in high-risk populations, allowing for rapid referral and better use of resources. 相似文献
110.
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. 总被引:5,自引:0,他引:5
Bruno Vincenzi Daniele Santini Giordano Dicuonzo Fabrizio Battistoni Michele Gavasci Annalisa La Cesa Claudia Grilli Vladimir Virzì Simona Gasparro Laura Rocci Giuseppe Tonini 《Journal of interferon & cytokine research》2005,25(3):144-151
The proven antiangiogenic activity of zoledronic acid, a third-generation bisphosphonate widely used in bone metastatic cancer patients, led us to investigate if the vascular endothelial growth factor (VEGF)-related zoledronic acid modifications are correlated with survival advantages in advanced breast cancer patients. Forty-two consecutive breast cancer patients with scintigraphic and radiographic evidence of bone metastases were treated with a single infusion of 4 mg zoledronic acid before anticancer chemotherapy. The patients were prospectively evaluated for circulating levels of VEGF and interferon-gamma (IFN-gamma) just before and at 1, 2, 7, and 21 days after zoledronic acid infusion. Afterward, clinical outcome was prospectively monitored. The basal serum VEGF median levels were significantly decreased at each time point, but the major reduction was recorded 21 days after the infusion. In particular, 25 patients of 42 (59.5%) experienced a reduction of at least 25% in the VEGF circulating levels. In contrast, no statistically significant modifications of the IFN-gamma serum levels were recorded. We stratified patients on the basis of this VEGF reduction 21 days after the infusion. No differences in patient features were recorded between those with or without the VEGF reduction. The analysis of survival showed that patients with a reduction in the VEGF circulating levels had a longer time to first skeletal-related event (p = 0.0002), time to bone progression disease (p = 0.0024), and time to performance status worsening (p = 0.0352) than those without the VEGF reduction. No statistically significant differences were recorded in terms of overall survival and time to visceral progression. This study confirms that zoledronic acid could have an in vivo antiangiogenic property and that the VEGF modifications may represent a surrogate marker able to predict time to first skeletal-related event, time to bone progression disease, and time to worsening of performance status. 相似文献